Literature DB >> 26142269

Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.

Wei Huang1, Yong Huang2, Jujie Sun3, Xibin Liu4, Jian Zhang5, Tao Zhou5, Baijiang Zhang3, Baosheng Li6.   

Abstract

PURPOSE: To construct an anatomical atlas of thoracic lymph node regions of esophageal cancer (EC) based on definitions from The Japan Esophageal Society (JES) and generate a consensus to delineate the nodal clinical target volume (CTVn) for elective nodal radiation (ENI) of esophageal squamous cell carcinoma (ESCC). METHODS AND MATERIALS: An interdisciplinary group including two dedicated radiation oncologists, an experienced radiologist, a pathologist and two thoracic surgeons were gathered to generate a three-dimensional radiological description for the mediastinal lymph node regions of EC on axial CT scans. Then the radiological boundaries of lymph node regions were validated by a relatively large number of physicians in multiple institutions.
RESULTS: An atlas of detailed anatomic boundaries of lymph node station No. 105-114 was defined on axial CT, along with illustrations. From the previous work, the study provided a guide of CTVn contouring for ENI of thoracic ESCC from a single center.
CONCLUSION: It is feasible to use such an atlas of thoracic lymph node stations for radiotherapy planning. A phase III study based on the atlas is ongoing in China to measure quantitatively the ENI received by patients with ESCC.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Esophageal cancer; Lymph nodes; Radiation therapy

Mesh:

Year:  2015        PMID: 26142269     DOI: 10.1016/j.radonc.2015.06.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.

Authors:  Yuanli Dong; Hui Guan; Wei Huang; Zicheng Zhang; Dongbo Zhao; Yang Liu; Tao Zhou; Baosheng Li
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

Review 2.  Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Authors:  Harushi Udagawa; Masaki Ueno
Journal:  Ann Transl Med       Date:  2018-02

3.  Mapping of Cervical and Upper Mediastinal Lymph Node Recurrence for Guiding Clinical Target Delineation of Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma.

Authors:  Yichun Wang; Dongmei Ye; Mei Kang; Liyang Zhu; Mingwei Yang; Jun Jiang; Wanli Xia; Ningning Kang; Xiangcun Chen; Jie Wang; Fan Wang
Journal:  Front Oncol       Date:  2021-04-26       Impact factor: 6.244

4.  Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.

Authors:  Brandon Garcia; Karyn A Goodman; Lajhem Cambridge; Mark Dunphy; Abraham J Wu
Journal:  Radiat Oncol       Date:  2016-11-25       Impact factor: 3.481

5.  Regional hyperthermia combined with radiotherapy for esophageal squamous cell carcinoma with supraclavicular lymph node metastasis.

Authors:  Liming Sheng; Yongling Ji; Qiner Wu; Xianghui Du
Journal:  Oncotarget       Date:  2017-01-17

6.  Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.

Authors:  Hong-Yao Xu; Sheng-Xi Wu; He-San Luo; Chu-Yun Chen; Lian-Xing Lin; He-Cheng Huang
Journal:  Radiat Oncol       Date:  2018-10-16       Impact factor: 3.481

7.  Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.

Authors:  Xi-Lei Zhou; Wei-Guo Zhu; Zhi-Jian Zhu; Wan-Wei Wang; Xue Deng; Wei-Jing Tao; Fu-Zhi Ji; Yu-Suo Tong
Journal:  Oncologist       Date:  2019-04-30

8.  Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated?

Authors:  Junmiao Wen; Donglai Chen; Ting Zhao; Jiayan Chen; Yuhuan Zhao; Di Liu; Wenjia Wang; Xinyan Xu; Min Fan; Chang Chen; Yongbing Chen
Journal:  Thorac Cancer       Date:  2019-07-10       Impact factor: 3.500

9.  Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume.

Authors:  Tiantian Cui; Hongjiao Zhang; Tao Yu; Yiru Chen; Chengxin Liu; Qian Zhao; Jian Zhu; Baosheng Li; Wei Huang
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

10.  Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.

Authors:  Xiao Chang; Lei Deng; Wenjie Ni; Chen Li; Weiming Han; Lin-Rui Gao; Shijia Wang; Zongmei Zhou; Dongfu Chen; Qinfu Feng; Jun Liang; Nan Bi; Jima Lv; Shugeng Gao; Yousheng Mao; Qi Xue; Zefen Xiao
Journal:  BMC Cancer       Date:  2020-09-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.